Article: Intake assessment of problematic use of medications in a chronic noncancer pain clinic.
2012 Volume 17, Issue 4, Page(s) 276–280
Abstract: Background: The present article outlines the process of instituting an assessment of risk of problematic use of medications with new patients in an ambulatory chronic noncancer pain (CNCP) clinic. It is hoped that the authors' experience through this ... ...
Abstract | Background: The present article outlines the process of instituting an assessment of risk of problematic use of medications with new patients in an ambulatory chronic noncancer pain (CNCP) clinic. It is hoped that the authors' experience through this iterative process will fill the gap in the literature by setting an example of an application of the 'universal precautions' approach to chronic pain management. Objectives: To assess the feasibility and utility of the addition of a new risk assessment process and to provide a snapshot of the risk of problematic use of medications in new patients presenting to a tertiary ambulatory clinic treating CNCP. Methods: Charts for the first three months following the institution of an intake assessment for risk of problematic medication use were reviewed. Health care providers at the Wasser Pain Management Centre (Toronto, Ontario) were interviewed to discuss the preliminary findings and provide feedback about barriers to completing the intake assessments, as well as to identify the items that were clinically relevant and useful to their practice. Results: Data were analyzed and examined for completeness. While some measures were considered to be particularly helpful, other items were regarded as repetitive, problematic or time consuming. Feedback was then incorporated into revisions of the risk assessment tool. Discussion: Overall, it is feasible and useful to assess risk for problematic use of medications in new patients presenting to CNCP clinics. Conclusion: To facilitate the practice of assessment, the risk assessment tool at intake must be concise, clinically relevant and feasible given practitioner time constraints. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Alcoholism/epidemiology ; Alcoholism/prevention & control ; Analgesics, Opioid/administration & dosage ; Analgesics, Opioid/adverse effects ; Chronic Pain/drug therapy ; Chronic Pain/epidemiology ; Hospitals, Teaching/statistics & numerical data ; Humans ; Outpatient Clinics, Hospital/statistics & numerical data ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; Substance-Related Disorders/epidemiology ; Substance-Related Disorders/prevention & control | |||||
Chemical Substances | Analgesics, Opioid | |||||
Language | English | |||||
Publishing date | 2012-08-13 | |||||
Publishing country | United States | |||||
Document type | Journal Article ; Research Support, Non-U.S. Gov't | |||||
ZDB-ID | 2041085-2 | |||||
ISSN | 1918-1523 ; 1203-6765 | |||||
ISSN (online) | 1918-1523 | |||||
ISSN | 1203-6765 | |||||
DOI | 10.1155/2012/489743 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5498: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.